Cargando…

c-Abl Tyrosine Kinase Adopts Multiple Active Conformational States in Solution

[Image: see text] Protein tyrosine kinases of the Abl family have diverse roles in normal cellular regulation and drive several forms of leukemia as oncogenic fusion proteins. In the crystal structure of the inactive c-Abl kinase core, the SH2 and SH3 domains dock onto the back of the kinase domain,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Badger, John, Grover, Prerna, Shi, Haibin, Panjarian, Shoghag B., Engen, John R., Smithgall, Thomas E., Makowski, Lee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2016
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910136/ https://www.ncbi.nlm.nih.gov/pubmed/27166638 http://dx.doi.org/10.1021/acs.biochem.6b00202

Ejemplares similares

Fluorescence Polarization Screening Assays for Small Molecule Allosteric Modulators of ABL Kinase Function
por: Grover, Prerna, et al.
Publicado: (2015)

A Src-Like Inactive Conformation in the Abl Tyrosine Kinase Domain
por: Levinson, Nicholas M, et al.
Publicado: (2006)

The Roles of DNA Demethylases in Triple-Negative Breast Cancer
por: Panjarian, Shoghag, et al.
Publicado: (2021)

Computational Study of the “DFG-Flip” Conformational Transition in c-Abl and c-Src Tyrosine Kinases
por: Meng, Yilin, et al.
Publicado: (2014)

Allosteric Interactions between the Myristate- and ATP-Site of the Abl Kinase
por: Iacob, Roxana E., et al.
Publicado: (2011)

Constitutive Activity in an Ancestral Form of Abl Tyrosine Kinase
por: Aleem, Saadat U., et al.
Publicado: (2015)

Bcr-Abl tyrosine kinase inhibitors- current status
por: Mughal, Anum, et al.
Publicado: (2013)

Tyrosine kinase c-Abl regulates the survival of plasma cells
por: Li, Yan-Feng, et al.
Publicado: (2017)

Abl Tyrosine Kinase Regulates Hepatitis C Virus Entry
por: Min, Saehong, et al.
Publicado: (2017)

Bcr-Abl Tyrosine Kinase Inhibitors in the Treatment of Pediatric CML
por: Carofiglio, Francesca, et al.
Publicado: (2020)

The Role of c-Abl Tyrosine Kinase in Brain and Its Pathologies
por: Motaln, Helena, et al.
Publicado: (2023)

Studying the Conformation of a Receptor Tyrosine Kinase in Solution by Inhibitor‐Based Spin Labeling
por: Yin, Dongsheng M., et al.
Publicado: (2017)

Successful treatment with ABL tyrosine kinase inhibitor for patients with acute myeloid leukemia with BCR-ABL1
por: Takeuchi, Asako, et al.
Publicado: (2020)

RIN1 regulates cell migration through RAB5 GTPases and ABL tyrosine kinases
por: Balaji, Kavitha, et al.
Publicado: (2013)

Role of the ABL tyrosine kinases in the epithelial–mesenchymal transition and the metastatic cascade
por: Luttman, Jillian Hattaway, et al.
Publicado: (2021)

Molecular basis for the interaction between human choline kinase alpha and the SH3 domain of the c-Src tyrosine kinase
por: Kall, Stefanie L., et al.
Publicado: (2019)

Deducing the Conformational Properties of a Tyrosine Kinase Inhibitor in Solution by Optical Spectroscopy and Computational Chemistry
por: Kabir, Md. Lutful, et al.
Publicado: (2020)

HIV-1 Nef interaction influences the ATP-binding site of the Src-family kinase, Hck
por: Pene-Dumitrescu, Teodora, et al.
Publicado: (2012)

Src- and Abl-family kinases activate spleen tyrosine kinase to maximize phagocytosis and Leishmania infection
por: Ullah, Imran, et al.
Publicado: (2023)

Novel Src/Abl tyrosine kinase inhibitor bosutinib suppresses neuroblastoma growth via inhibiting Src/Abl signaling
por: Bieerkehazhi, Shayahati, et al.
Publicado: (2016)

Cockayne syndrome protein B interacts with and is phosphorylated by c-Abl tyrosine kinase
por: Imam, Syed Z., et al.
Publicado: (2007)

Imatinib and tyrosine kinase inhibition, in the management of BCR-ABL negative myeloproliferative disorders
por: Mesa, Ruben A
Publicado: (2007)

Cbl-associated protein is tyrosine phosphorylated by c-Abl and c-Src kinases
por: Fernow, Inga, et al.
Publicado: (2009)

BCR-ABL1 tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia
por: Cuellar, Sandra, et al.
Publicado: (2017)

RUNX2 Phosphorylation by Tyrosine Kinase ABL Promotes Breast Cancer Invasion
por: He, Fang, et al.
Publicado: (2021)

c-Abl Tyrosine Kinase Is Required for BDNF-Induced Dendritic Branching and Growth
por: Chandía-Cristi, América, et al.
Publicado: (2023)

Accelerated aging in normal breast tissue of women with breast cancer
por: Panjarian, Shoghag, et al.
Publicado: (2021)

Differential Sensitivity of Src-Family Kinases to Activation by SH3 Domain Displacement
por: Moroco, Jamie A., et al.
Publicado: (2014)

Evaluation of residue variability in a conformation‐specific context and during evolutionary sequence reconstruction narrows drug resistance selection in Abl1 tyrosine kinase
por: Otsuka, Felipe A. M., et al.
Publicado: (2022)

Structural and Spectroscopic Analysis of the Kinase Inhibitor Bosutinib and an Isomer of Bosutinib Binding to the Abl Tyrosine Kinase Domain
por: Levinson, Nicholas M., et al.
Publicado: (2012)

Abl Tyrosine Kinase Phosphorylates Nonmuscle Myosin Light Chain Kinase to Regulate Endothelial Barrier Function
por: Dudek, Steven M., et al.
Publicado: (2010)

Effect of c-Abl tyrosine kinase on the cellular response to paclitaxel-induced microtubule damage
por: Nehmé, A, et al.
Publicado: (2000)

cGMP-mediated antioxidant signaling: a role for the c-Abl tyrosine kinase
por: Stephens, Robert S, et al.
Publicado: (2011)

Importance of adherence to BCR-ABL tyrosine-kinase inhibitors in the treatment of chronic myeloid leukemia
por: de Almeida, Maria Helena, et al.
Publicado: (2014)

Bosutinib: a SRC–ABL tyrosine kinase inhibitor for treatment of chronic myeloid leukemia
por: Rassi, Fuad El, et al.
Publicado: (2013)

Structural and functional dissection of the DH and PH domains of oncogenic Bcr-Abl tyrosine kinase
por: Reckel, Sina, et al.
Publicado: (2017)

A Role for the Non-Receptor Tyrosine Kinase Abl2/Arg in Experimental Neuroinflammation
por: Jacobsen, Freja Aksel, et al.
Publicado: (2018)

Interaction of Abl Tyrosine Kinases with SOCS3 Impairs Its Suppressor Function in Tumorigenesis()()()
por: Feng, Riyue, et al.
Publicado: (2018)

BCR-ABL Tyrosine Kinase Inhibitors: Which Mechanism(s) May Explain the Risk of Thrombosis?
por: Haguet, Hélène, et al.
Publicado: (2018)

BCR-ABL tyrosine kinase inhibitor (TKI)-induced nephropathy: An under-recognized phenomenon
por: Stanchina, Michele, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gihqvd31csul0t9p3mm9qma64q